Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes

被引：0
|
作者：
Moumita Sarkar
Gideon Koren
Sanjog Kalra
Angela Ying
Carlo Smorlesi
Marco De Santis
Orna Diav-Citrin
Meytal Avgil
Sharon Voyer Lavigne
Matti Berkovich
Adrienne Einarson
机构：
[1] The Motherisk Program,Division of Clinical Pharmacology
[2] Servicio di Tossicologica Perinatale,undefined
[3] Telefono Rosso,undefined
[4] Israel Teratogen Information,undefined
[5] Connecticut Pregnancy Riskline,undefined
[6] Tel Aviv University,undefined
[7] The Hospital for Sick Children,undefined
来源：
European Journal of Clinical Pharmacology | 2009年 / 65卷
关键词：
Asthma; Malformations; Pregnancy; Montelukast; Preterm delivery; Low birth weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1259 / 1264
页数：5
相关论文
共 50 条
  • [41] Prospective study of pregnancy and newborn outcomes in mothers with West nile illness during pregnancy
    Pridjian, Gabriella
    Sirois, Patricia A.
    McRae, Scott
    Hinckley, Alison F.
    Rasmussen, Sonja A.
    Kissinger, Patricia
    Buekens, Pierre
    Hayes, Edward B.
    O'Leary, Dan
    Kuhn, Stephanie
    Swan, Kenneth F.
    Xiong, Xu
    Wesson, Dawn M.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2016, 106 (08) : 716 - 723
  • [42] A prospective cohort study evaluating pregnancy outcomes and risk perceptions of pregnant women following glucosamine use during pregnancy.
    不详
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (05) : 395 - 395
  • [43] Parental cannabis use during preconception and pregnancy: Longitudinal associations with infant birth outcomes
    Hutchinson, Delyse M.
    Aarsman, Stephanie
    Weller, Emmelyn
    Le Bas, Genevieve
    Greenwood, Christopher J.
    Youssef, George
    Mattick, Richard
    Elliott, Elizabeth
    Allsop, Steve
    Burns, Lucy
    Najman, Jake
    Jacobs, Sue
    Olsson, Craig A.
    Teague, Samantha
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S90 - S91
  • [44] Infant Growth Outcomes After Maternal Tenofovir Disoproxil Fumarate Use During Pregnancy
    Ransom, Carla E.
    Huo, Yanling
    Patel, Kunjal
    Scott, Gwendolyn B.
    Watts, Heather D.
    Williams, Paige
    Siberry, George K.
    Livingston, Elizabeth G.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 64 (04) : 374 - 381
  • [45] Symptomatic Dengue Infection during Pregnancy and Infant Outcomes: A Retrospective Cohort Study
    Friedman, Eleanor E.
    Dallah, Fadi
    Harville, Emily W.
    Myers, Leann
    Buekens, Pierre
    Breart, Gerard
    Carles, Gabriel
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (10):
  • [46] The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan
    Hatakeyama, Shiro
    Goto, Mikako
    Yamamoto, Ayaka
    Ogura, Jiro
    Watanabe, Norikazu
    Tsutsumi, Seiji
    Yakuwa, Naho
    Yamane, Ritsuko
    Nagase, Satoru
    Takahashi, Kunihiko
    Kosaki, Rika
    Murashima, Atsuko
    Yamaguchi, Hiroaki
    CONGENITAL ANOMALIES, 2022, 62 (04) : 161 - 168
  • [47] USE OF MEDICATION DURING PREGNANCY - A PROSPECTIVE COHORT STUDY ON USE AND POLICY OF PRESCRIBING
    HEIKKILA, AM
    ERKKOLA, RU
    NUMMI, SE
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1994, 83 : 80 - 83
  • [48] Pregnancy outcome following gestational exposure to montelukast: A prospective cotrolled study.
    Sarkar, M
    Koren, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P30 - P30
  • [49] Depression during pregnancy and infant's gender: A prospective case-control study
    Wendland, J.
    Gerardin, P.
    Bodeau, N.
    Galin, A.
    Bialobos, S.
    Tordjman, S.
    Mazet, P.
    Darbois, Y.
    Nizard, J.
    Dommergues, M.
    Cohen, D.
    INFANT MENTAL HEALTH JOURNAL, 2010, 31 (03) : 175 - 175
  • [50] Substance use during pregnancy and child outcomes: a longitudinal study
    Imaz, M.
    Gelabert, E.
    Garcia-Esteve, L. L.
    Navarro, P.
    Sanjuan, J.
    Guillamat, R.
    Gutierrez, A.
    Torrens, M.
    Langorh, K.
    Martin-Santos, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S674 - S674
12345